» Articles » PMID: 29781221

Aberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4-Related Disease

Overview
Publisher Wiley
Specialty Rheumatology
Date 2018 May 22
PMID 29781221
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the number and function of follicular helper T (Tfh) cell subsets in IgG4-related disease (IgG4-RD).

Methods: Mononuclear cells from the peripheral blood and involved tissue of patients with IgG4-RD were assessed for Tfh cells and their subsets, and levels of B cell lymphoma 6 (Bcl-6), B lymphocyte-induced maturation protein 1 (BLIMP-1), and interleukin-21 (IL-21) messenger RNA (mRNA). Immunohistochemical and immunofluorescence techniques were used to assess the involved tissue of patients to determine the location of IL-21, Bcl-6, and CD4+CXCR5+ Tfh cells. Furthermore, the ability of circulating Tfh (cTfh) cell subsets to induce B cell proliferation, apoptosis, and differentiation and to produce IgG4 was explored in cell cocultures in vitro.

Results: Frequencies of cTfh cells were significantly increased in the peripheral blood of patients with IgG4-RD, and even higher frequencies were observed in the involved tissue. Percentages of programmed cell death protein 1 in CD4+CXCR5+ICOS+ cTfh cells were positively correlated with the serum levels of IgG and IgG4, IgG4:IgG ratio, number of involved organs, and frequency of CD19+CD24-CD38 plasmablasts/plasma cells. Levels of BLIMP-1 and IL-21 mRNA in peripheral CD4+ T cells were increased in patients with IgG4-RD compared to healthy controls, and this was correlated with the levels of serum IgG4. Moreover, in the involved tissue, Bcl-6, IL-21, and Tfh cells were highly expressed. Compared to cTfh cells from healthy controls, cTfh cells from patients with IgG4-RD could facilitate B cell proliferation and inhibit B cell apoptosis more efficiently, and enhanced the differentiation of naive B cells into switched memory B cells and plasmablasts/plasma cells, with a resultant increase in the secretion of IgG4. Notably, the cTfh1 and cTfh2 cell subsets were the most effective at providing B cell help.

Conclusion: Tfh cell subsets are expanded in IgG4-RD and may play pivotal roles in the pathogenesis of the disease.

Citing Articles

Recent Evidence of the Role of CD4 T Cell Subsets in IgG4-related Disease.

Kamekura R, Sakamoto H, Yajima R, Yamamoto K, Okuni T, Yamamoto M JMA J. 2025; 8(1):40-47.

PMID: 39926068 PMC: 11799721. DOI: 10.31662/jmaj.2024-0096.


Immune Profile Differences between IgG4-Related Diseases and Primary Sjögren's Syndrome.

Qin Y, Shang L, Wang Y, Feng M, Liang Z, Wang N J Inflamm Res. 2025; 18:911-923.

PMID: 39871956 PMC: 11770921. DOI: 10.2147/JIR.S471266.


Pharmacological Management of IgG4-Related Disease: From Traditional to Mechanism-Based Targeted Therapies.

Akiyama M, Alshehri W, Saito K, Takeuchi T, Kaneko Y Drugs Aging. 2025; 42(2):111-126.

PMID: 39755996 DOI: 10.1007/s40266-024-01172-3.


A positive cytokine/chemokine feedback loop establishes plasmacytoid DC-driven autoimmune pancreatitis in IgG4-related disease.

Hara A, Watanabe T, Minaga K, Yoshikawa T, Kurimoto M, Sekai I JCI Insight. 2024; 9(20).

PMID: 39264798 PMC: 11529986. DOI: 10.1172/jci.insight.167910.


IgG4-Related Disease (IgG4-RD) with Unique Combined Generalized Skin Rashes and Biliary Tract Manifestation: A Comprehensive Immunological Analysis.

Jung Y, Agrawal S, Wang B, Gupta S Dermatopathology (Basel). 2024; 11(3):218-229.

PMID: 39051325 PMC: 11270352. DOI: 10.3390/dermatopathology11030023.


References
1.
Lin W, Zhang P, Chen H, Chen Y, Yang H, Zheng W . Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease. Arthritis Res Ther. 2017; 19(1):25. PMC: 5301376. DOI: 10.1186/s13075-017-1231-2. View

2.
Locci M, Havenar-Daughton C, Landais E, Wu J, Kroenke M, Arlehamn C . Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity. 2013; 39(4):758-69. PMC: 3996844. DOI: 10.1016/j.immuni.2013.08.031. View

3.
Crotty S . T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014; 41(4):529-42. PMC: 4223692. DOI: 10.1016/j.immuni.2014.10.004. View

4.
Mesquita Jr D, Cruvinel W, Resende L, Mesquita F, Silva N, Camara N . Follicular helper T cell in immunity and autoimmunity. Braz J Med Biol Res. 2016; 49(5):e5209. PMC: 4843212. DOI: 10.1590/1414-431X20165209. View

5.
Weber J, Fuhrmann F, Feist R, Lahmann A, Al Baz M, Gentz L . ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2. J Exp Med. 2015; 212(2):217-33. PMC: 4322049. DOI: 10.1084/jem.20141432. View